跳至主要内容
临床试验/CTRI/2023/02/049798
CTRI/2023/02/049798招募中2 期

A phase 2 study of SBRT in extracranial oligometastatic disease and its impact on overall survival and quality of life (SBRT-ECOMD) - SBRT-ECOMD

PGIMER CHANDIGARH0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1) Lymph node, bone, liver, lung oligometastatic disease
  • 2) All primary tumors of colorectal, gastric, esophagus, lung, breast, gynaecological cancers or any other site
  • 3) A controlled primary tumor
  • 4) A life expectancy of more than 6 months
  • 5) KPS = 70
  • 6) Age > 18 years

排除标准

  • More than 5 metastases
  • 2) KPS = 60
  • 3) Pre-existing collagen vascular disease
  • 4) Age < 18 years
  • 5) Pregnant and Lactating women
  • 6) Disseminated disease

研究者

相似试验

SBRT in extracranial oligometastatic disease and its... | 临床试验